| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
InMed Pharmaceuticals Inc (F: MWG)
MWG Technical Analysis
5
| As on 6th Sep 2022 MWG STOCK Price closed @ 0.37 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.84 & Strong Sell for SHORT-TERM with Stoploss of 2.60 we also expect STOCK to react on Following IMPORTANT LEVELS. |
MWGSTOCK Price
| Open | 0.33 | Change | Price | % |
| High | 0.37 | 1 Day | 0.04 | 12.12 |
| Low | 0.33 | 1 Week | 0.09 | 32.14 |
| Close | 0.37 | 1 Month | 0.01 | 2.78 |
| Volume | 40000 | 1 Year | -2.83 | -88.44 |
| 52 Week High 3.20 | 52 Week Low 0.25 | ||||
F Germany Most Active Stocks
| ENB | 47.60 | -0.92% |
| TEF | 3.84 | -0.52% |
| TEF | 3.84 | -0.52% |
| WHL | 5150.00 | -0.44% |
| WDI | 0.05 | -37.50% |
| WDI | 0.05 | -37.50% |
| WDI | 0.05 | -37.50% |
| WDI | 0.05 | -37.50% |
| WDI | 0.05 | -37.50% |
| TOE | 0.02 | 0.00% |
F Germany Top Gainers Stocks
F Germany Top Losers Stocks
| MWG Daily Charts |
MWG Intraday Charts |
Whats New @ Bazaartrend |
MWG Free Analysis |
|
|
MWG Important Levels Intraday
| RESISTANCE | 0.45 |
| RESISTANCE | 0.42 |
| RESISTANCE | 0.41 |
| RESISTANCE | 0.39 |
| SUPPORT | 0.35 |
| SUPPORT | 0.33 |
| SUPPORT | 0.32 |
| SUPPORT | 0.29 |
MWG Forecast May 2024
| 4th UP Forecast | 2.14 |
| 3rd UP Forecast | 1.57 |
| 2nd UP Forecast | 1.22 |
| 1st UP Forecast | 0.87 |
| 1st DOWN Forecast | -0.13 |
| 2nd DOWN Forecast | -0.48 |
| 3rd DOWN Forecast | -0.83 |
| 4th DOWN Forecast | -1.4 |
MWG Weekly Forecast
| 4th UP Forecast | 1.06 |
| 3rd UP Forecast | 0.84 |
| 2nd UP Forecast | 0.70 |
| 1st UP Forecast | 0.57 |
| 1st DOWN Forecast | 0.17 |
| 2nd DOWN Forecast | 0.04 |
| 3rd DOWN Forecast | -0.10 |
| 4th DOWN Forecast | -0.32 |
MWG Forecast2024
| 4th UP Forecast | 6.05 |
| 3rd UP Forecast | 4.23 |
| 2nd UP Forecast | 3.1 |
| 1st UP Forecast | 1.98 |
| 1st DOWN Forecast | -1.24 |
| 2nd DOWN Forecast | -2.36 |
| 3rd DOWN Forecast | -3.49 |
| 4th DOWN Forecast | -5.31 |
InMed Pharmaceuticals Inc ( F Germany Symbol : MWG )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
MWG Business Profile
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-405 for the treatment of pain. In addition, it engages in the development of cannabinoid-based treatments for various diseases, including dermatology and ocular diseases. Further, the company works on IND-enabling pharmacology and preclinical toxicology studies; and IntegraSyn, an integrated biosynthesis-based manufacturing approach, for synthesizing pharmaceutical-grade cannabinoids. It has a research collaboration agreement with BayMedica Inc. for the manufacturing and testing of novel cannabinoid therapeutics. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is headquartered in Vancouver, Canada. Address: 815 West Hastings Street, Vancouver, BC, Canada, V6C 1B4
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service